Iris Isufi, MD

Assistant Professor of Medicine (Hematology)

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Hematology Program


Transplantation Center, Yale-New Haven

Yale Medical Group

Board Certifications

  • Medical Oncology AB of Internal Medicine (2011)

  • Internal Medicine AB of Internal Medicine (2007)

Clinical Trials

Conditions Study Title
Multiple Myeloma Study of High-dose Influenza Vaccine Efficacy by Repeated dosing IN Gammopathy patients: A 2 Arm randomized study (SHIVERING 2 Trial)
Multiple Myeloma A Phase 1b Study of the Safety and Pharmacokinetics of MPDL3280A (Anti-PD-L1 Antibody) Alone or in Combination with Lenalidomide in Patients with Multiple Myeloma (Relapsed and Post-Autologous Stem Cell Transplantation)
Myeloid and Monocytic Leukemia A Randomized Phase III Study of Standard Cytarabine Plus Daunomycin (7+3) Therapy versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)
Multiple Myeloma Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic High-Risk Smoldering Multiple Myeloma
Multiple Myeloma S1304, A Phase II Randomized Study Comparing Two Doses of Carfilzomib (NSC-756640) with Dexamethasone for Multiple Myeloma Patients with Relapsed or Refractory Disease
Mycosis Fungoides A Phase 2 Study of MK-3475 for the treatment of Relapsed/Refractory Mycosis Fungoides/Sézary Syndrome
Leukemia, other A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (≥65 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
Lymphoid Leukemia E1912: A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
Multiple Myeloma Immunology and Pathobiology of Plasma Cell Disorders
Ill-Defined Sites A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications
Unknown Sites The National Marrow Donor Program and Center for International Blood and Marrow Transplant Research Protocol for a Research Sample Repository for Related and Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma A Phase II Trial of PET-Directed Therapy for Limited Stage Diffuse Large B-cell Lymphoma (SWOG S1001)

Edit this profile

Contact Info

Iris Isufi, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street, Ste North Pavilion 7

New Haven, CT 06510
Mailing Address
333 Cedar Street FMP 130
PO Box 208032

New Haven, CT 06520-8032